Sancilio & Company

We are a fully integrated specialty pharmaceutical company, engaged in the research, development, manufacturing & commercialization of pharmaceutical product candidates that utilize our proprietary Advanced Lipid Technologies?. ALT is designed to enhance the bioavailability of lipid & lipophilic active pharmaceutical ingredients. We have 6 pharmaceutical product candidates in our pipeline that are under development. In addition, we provide third party pharmaceutical companies with licenses to our technologies. We are assisting third parties in the development of ANDAs & 505(b)(2) New Drug Applications, or NDAs. Whether for our own portfolio or for third parties, the product candidates contain APIs that consist of substances already approved by the FDA for similar indications or for substances generally regarded as safe. Mission:?To Save a Million Lives